New Study

Shorter Survival for Mesothelioma Patients Linked to Specific Biomarker

Mesothelioma is a very aggressive cancer with a poor prognosis. When diagnosed, patients can sometimes be given just a few months to live.  Doctors and researchers are continuing to find treatment options to help cure, extend, or at least make patients’ lives better. Some researchers are looking at biomarkers, which[…]

Read More »

There is a Possible New Way to Diagnose Pleural Mesothelioma

Researchers have possibly found a less invasive way to diagnose pleural mesothelioma. By looking at the patient’s medical history and using CT scans, researchers at the Universite Laval in Quebec have found that imaging technology can be used potentially to benefit very sick patients. Doctors have never been able to[…]

Read More »

First FDA Approved Mesothelioma Treatment in 15 Years to be Used Soon

A new cancer treatment using electricity has been approved for use in mesothelioma patients. The NovoTTF-100L uses Tumor Treating Fields, which are electric signals tuned to a specific frequency, to disrupt cancerous cell division. The fields are applied to the patient with adhesive bandages and are used for at least[…]

Read More »

MicroRNA Could be used to Quickly Diagnose Mesothelioma

Biomarkers are measureable substances that indicate if someone has a disease. Doctors and researchers are able to find different substances within a person’s body and deduce that the person has a specific type of cancer. Researchers have found a relatively new biomarker called microRNA, which could possibly be used to[…]

Read More »

Mesothelioma Diagnosis Rates Have Remained Stable even though Mesothelioma Survival has Improved

It was found that the number of pleural mesothelioma diagnoses has stayed the same, while the survival rate for people with the disease has slightly improved. Once asbestos was not used as much because of multiple regulations, the number of diagnoses of mesothelioma was predicted to go down. Instead, the[…]

Read More »

Potential New Treatment Acts as a Sealant for Pleural Mesothelioma Tumors

Pleural mesothelioma, caused by exposure to asbestos is a rare cancer – only 3,000 cases are diagnosed in the U.S. each year – but it is highly aggressive. There is no cure for plural mesothelioma but findings published in the Journal of Thoracic and Cardiovascular Surgery reveal that a new[…]

Read More »

First FDA Approved Treatment for Mesothelioma in 15 Years

In the Fall of 2018 scientists and researchers from Novocure, an oncology company that specializes in treating solid tumors, were hopeful their latest success with Tumor Treating Fields therapy would lead to FDA approval and ultimately, more options for those suffering from mesothelioma. After a successful clinical trial, these hopes[…]

Read More »

Currently Recruiting: Mesothelioma Clinical Trials

When it comes to effective mesothelioma treatments, options are unfortunately limited. There is no cure for mesothelioma and first line chemotherapy treatment Alimta, is no guarantee.  Many who are suffering from mesothelioma, who have found little or no comfort in traditional treatments, may turn to clinical trials for hope.  Through[…]

Read More »